Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
106.29
+0.32 (+0.30%)
Official Closing Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
Why Shares of Quidel Surged 10% This Week
September 02, 2021
Demand for its COVID tests are rising with cases.
Via
The Motley Fool
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
September 02, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
This May Be Abbott's Billion-Dollar Opportunity
September 02, 2021
Abbott delivered bad news back in June. But the tide has turned.
Via
The Motley Fool
Exposures
COVID-19
Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study
August 30, 2021
Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer...
Via
Benzinga
See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests
August 27, 2021
CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The...
Via
Benzinga
Exposures
COVID-19
Where Abbott Laboratories Stands With Analysts
August 21, 2021
Within the last quarter, Abbott Laboratories (NYSE:ABT) has ...
Via
Benzinga
Podcast: How to Find STEM Success? Learn to Pivot.
August 18, 2021
SOURCE: Abbott
Via
3BL Media
A Workplace Where Collaboration = Innovation
August 09, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Healthcare Stocks Hit New Highs but Small Caps Lag
August 23, 2021
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field.
Via
Talk Markets
Abbott Destroyed Several COVID Test Cards, Now Faces Diminished Capacity: NYT
August 23, 2021
When demand for rapid COVID-19 screening dropped earlier this year, Abbott Laboratories (NYSE: ABT) lowered its financial outlook for full-year 2021 and ...
Via
Benzinga
Exposures
COVID-19
NeuroSphere Virtual Clinic Brings Relief to Rural Town
August 23, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
Lead
AbbVie: Dividend Stock to Buy?!
August 21, 2021
The quest to find undervalued dividend stocks to buy in this hot stock market continues. The S&P 500 continues to trend higher and set record highs, even though we’ve had a few down days recently.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
FDA Approves Abbott's Atrial Fibrillation Device For LAA Occlusion
August 16, 2021
The
Via
Benzinga
Exposures
Product Safety
Abbott's Freestyle® Libre 2 IOS App Cleared In U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
August 13, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
Product Safety
Where Abbott Laboratories Stands With Analysts
July 23, 2021
Analysts have provided the following ratings for Abbott Laboratories (NYSE:
Via
Benzinga
How Spinoffs Affect Your Stocks
August 11, 2021
When stocks you own spins off a segment or division of its business, the company you own changes. This can change not only the future prospects of the company you own but also its historical...
Via
Talk Markets
2 Stocks That Could Turn $200,000 Into $1,000,000 in 10 Years
August 10, 2021
Both of these companies know something about beating the market.
Via
The Motley Fool
1 Healthcare Dividend Giant to Bank On Right Now
August 06, 2021
The pipeline and consistent dividend history of this Dividend Aristocrat mean its payout is likely to remain strong.
Via
The Motley Fool
A Convergence of Challenges: Addressing the Devastating Impact of Chronic Disease on Communities in Crisis
August 06, 2021
SOURCE: Abbott
Via
3BL Media
Topics
Death
Exposures
Death
Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments
August 05, 2021
Via
FinancialNewsMedia
Moderna’s (MRNA) Massive Market Cap
August 04, 2021
As could have been expected in the midst of a global pandemic, one of the most rapidly growing companies has been vaccine producer Moderna.
Via
Talk Markets
Got $5,000? Buy and Hold These 3 Market-Beating Stocks
August 04, 2021
They're likely to continue to outperform the market.
Via
The Motley Fool
Broader Access is Vital to the Future of Testing and Healthcare Innovation
August 04, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Analyzing Abbott Laboratories's Unusual Options Activity
July 28, 2021
Shares of Abbott Laboratories (NYSE:ABT) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $120.62. Sentiment:...
Via
Benzinga
Understanding Abbott Laboratories's Unusual Options Activity
July 23, 2021
On Friday, shares of Abbott Laboratories (NYSE:ABT) saw unusual options activity. After the option alert, the stock price moved up to $120.16. Sentiment: BULLISH Option Type:...
Via
Benzinga
Analyzing Abbott Laboratories's Unusual Options Activity
July 23, 2021
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Friday. The stock price moved up to $120.17 following the option alert. Sentiment: BULLISH Option...
Via
Benzinga
Building Trust and Improving Care in Underserved Communities
July 23, 2021
SOURCE: Abbott
Via
3BL Media
Exposures
COVID-19
Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
July 22, 2021
ABT earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Covid-19 Tests Innovations Drawing New Interest from FDA and Consortiums
July 22, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
Abbott Q2 Profit More Than Doubles As Medical Device Sales Rebound
July 22, 2021
Abbott Laboratories Q2 profit more than doubled to $2.1 billion due to strength in its diagnostics business and a rebound in medical device sales.
Via
Talk Markets
< Previous
1
2
...
28
29
30
31
32
33
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.